Moderate-term effect of epoprostenol on severe portopulmonary hypertension

Pediatric Cardiology

Volumn 24, Issue 1, 2003, Pages 50-53

  Kato, H ^a   Katori, T ^a   Nakamura, Y ^a   Kawarasaki, H ^b  

^a UNIVERSITY OF TOKYO HOSPITAL   (Japan)

^b JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Biliary atresia; Epoprostenol; Liver transplantation; Portopulmonary hypertension

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; PROSTACYCLIN; ANTIHYPERTENSIVE AGENT;

BILE DUCT ATRESIA; CASE REPORT; CONFERENCE PAPER; DISEASE COURSE; DISEASE SEVERITY; DRUG EFFECT; DRUG INFUSION; DRUG SAFETY; ECHOCARDIOGRAPHY; FEMALE; HEMODYNAMICS; HUMAN; LIVER TRANSPLANTATION; PULMONARY HYPERTENSION; SCHOOL CHILD; TREATMENT OUTCOME; ARTICLE; CHILD; HOSPITALIZATION; INTRAVENOUS DRUG ADMINISTRATION; PORTAL HYPERTENSION;

ANTIHYPERTENSIVE AGENTS; CHILD; EPOPROSTENOL; FEMALE; HUMANS; HYPERTENSION, PORTAL; HYPERTENSION, PULMONARY; INFUSIONS, INTRAVENOUS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 0038659661     PISSN: 01720643     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00246-002-0120-9     Document Type: Conference Paper

References (10)

1. Barst RJ, Rubin LJ, Long WA, et al. (1996) A comparison of continuous intravenous epoprostenol with conventional therapy for primary pulmonary hypertension. N Engl J Med 334:296-302
2. Cheng EY, Woehlck HJ (1992) Pulmonary artery hypertension complicating anesthesia for liver transplantation. Anesthesiology 77:389-392
3. Edwards BS, Weir EK, Edwards WD, et al. (1987) Co-existent pulmonary and portal hypertension: morphologic and clinical features. J Am Coll Cardiol 10:1233-1238
4. Krowka NJ (1987) Hepatopulmonary hypertension and portopulmonary hypertension: distinctions and dilemmas. Hepatology 25:1282-1284
5. Krowka NJ, Franz RP, McGoon MD, et al. (1999) Improvement in pulmonary hemodynamics during intravenous epoprostenol (prostacyclin): a study of 15 patients with moderate to severe portopulmonary hypertension. Hepatology 30:641-648
6. Kunieda T, Kawai C, Shirado K, et al. (1998) Clinical evaluation of epoprostenol sodium in patients with primary pulmonary hypertension. Rinsho Iyaku 14:1091-1119
7. Kuo PC, Johnson LB, Plotkin JS, et al. (1997) Continuous intravenous infusion of epoprostenol for the treatment of portopulmonary hypertension. Transplantation 63:604-606
8. Kuo PC, Plotkin JS, Gaine S, et al. (1999) Portopulmonary hypertension and the liver transplant candidate. Transplantation 67:1087-1093
9. Mair P, Kaehler CH, Pomaroli A, et al. (2001) Orthotopic liver transplantation in a patient with severe portopulmonary hypertension. Acta Anaesthesiol Scand 45:513-518
10. Plotkin JS, Kuo PC, Rubin LJ, et al. (1998) Successful use of chronic epoprostenol as a bridge to liver transplantation in severe portopulmonary hypertension. Transplantation 65:457-459